For most people without cardiovascular disease, taking low-dose aspirin may do more harm than good, a federal task force concluded.
The task force’s analysis found that the benefits of aspirin for preventing cardiovascular disease is about the same for doses from 50 milligrams to 500 milligrams. Those who benefit most from taking a daily low-dose aspirin tablet are people with greater than a 15% or 20% risk for developing cardiovascular disease over a 10-year period, according to the recommendation, published in JAMA on Tuesday. The key recommendation applies only to those 40 years and older who don’t have cardiovascular disease or signs of it, who have no history of cardiovascular disease, who are not taking aspirin for another condition, and who aren’t at increased risk for bleeding. The task force still leaves the decision of whether to use aspirin for prevention up to individuals and their doctors — especially for those 40 to 59 years old — but refutes the old idea that the drug is totally harmless, Nissen said. Those assigned male at birth bear the brunt of cardiovascular disease and its effects on quality of life, but those assigned female at birth are more likely to die from cardiovascular issues, including stroke, which they experience later in life than men. Among adults 40 to 59 years old, the task force, a volunteer group of medical experts, concluded “with moderate certainty” that there was a small net benefit to taking low-dose aspirin among those who have a 10% or higher risk of developing heart disease in a 10-year period. In those ages 60 to 69 who met that 10% risk threshold, the 2016 recommendation left the choice of whether to begin aspirin up to individuals and their doctors.
An advisory panel of leading physicians no longer recommends daily low-dose aspirin for the prevention of heart attacks in adults age 60 and older, ...
Aspirin may, however, reduce the risk for heart attacks in some people with coronary artery disease, which causes a reduction of blood flow to the heart muscle due to build-up of plaque in the arteries, studies indicate. "Those without coronary artery disease should not take aspirin -- particularly those over the age of 60, as the risk of bleeding outweighs any potential benefit," he said. "I think that [these recommendations] really help us clarify a longstanding question -- who should get aspirin for coronary artery disease and how long should it be given," Campbell said. In addition to the known side effects associated with regular use, recent studies have found that low-dose aspirin does not reduce the risk for heart disease in everyone who uses it. In his practice, he has been recommending aspirin for secondary prevention only, meaning in patients with "known, documented coronary artery disease." However, for younger adults ages 40 to 59 years who have a greater than 10% risk for developing heart disease over the next decade of their lives -- and are at low risk for bleeding-related side effects associated with aspirin use -- the decision should be made on an individual bases, the group said.
New recommendations on the use of low-dose aspirin to prevent a first heart attack or stroke say the blood thinner's risks may outweigh its benefits, ...
Low-dose aspirin had been a popular prevention measure, but as more evidence has accumulated its benefit has come into question. On Tuesday the task force ...
You may click on “Your Choices” below to learn about and use cookie management tools to limit use of cookies when you visit NPR’s sites. If you click “Agree and Continue” below, you acknowledge that your cookie choices in those tools will be respected and that you otherwise agree to the use of cookies on NPR’s sites. NPR’s sites use cookies, similar tracking and storage technologies, and information about the device you use to access our sites (together, “cookies”) to enhance your viewing, listening and user experience, personalize content, personalize messages from NPR’s sponsors, provide social media features, and analyze NPR’s traffic.
The US Preventive Service Task Force has finalized its latest recommendations on low-dose aspirin regimens and now says people over 60 should not start ...
"When you look at all the studies that have been done recently, it seems that the modest benefit of aspirin and otherwise low-risk individuals is generally negated by the increase in long-term GI problems, bleeding with aspirin," Blumenthal said. The last time the task force updated these recommendations, in 2016, it suggested that daily aspirin could be of benefit in colorectal cancer prevention. Low-dose aspirin was also associated with increases in the risk of bleeding. This means your chance of having a heart attack or stroke in the next 10 years is higher than normal, based on a calculation that includes factors like age, sex, race, cholesterol levels, blood pressure, medication use, diabetic status and smoking status. , chair of cardiovascular medicine at Cleveland Clinic, who was not involved in the new guidelines. Your risk of bleeding will exceed the benefits," said Dr. Steven Nissen
TUESDAY, April 26, 2022 (HealthDay News) -- It seemed a simple prospect — take a low-dose baby aspirin tablet once a day and reduce your risk of ever suffering ...
The new recommendation does not apply to people with existing heart problems who are taking low-dose aspirin, Yang said. "We found that the taking of an aspirin on a daily basis might increase the odds of having a major gastrointestinal bleed, such as an ulcer, by about 60%," he said. By clicking submit, you are agreeing to our Terms and Conditions & Privacy Policy. "Some will elect to continue, but most patients will say, 'I don't want to take all these extra pills.'" The update brings the task force recommendations closer in line with the primary prevention guidelines of the American Heart Association and the American College of Cardiology. Those guidelines were revised in 2019 to recommend that no one 70 or older start taking aspirin to prevent a stroke or heart attack, Yang and Wong said. The choice for people between 40 and 59 would be between themselves and their doctor, but the task force warns that the "net benefit of aspirin use in this group is small."
In fact, scientists believe that it can lead to internal bleeding inside the stomach or brain as people get older. Heart attacks are responsible for one in four ...
The task force's updated guidelines recommend against starting low-dose aspirin use for the prevention of heart attack in adults who are above 60-years-old. In its previous guidelines that were released in 2016, the USPSTF had it recommended that people in their 50s, who are at risk for heart disease, should take baby aspirin to prevent both cardiovascular disease and colon cancer. The task force's updated guidelines recommend against starting low-dose aspirin use for the prevention of heart attack in adults who are above 60-years-old
After years of recommending regular aspirin to prevent heart attack and stroke, scientists now see little benefit for most healthy people, and say it may ...
CTV News was able to find a vehicle stolen from an Ontario street more than six months earlier. CTV News was able to find a vehicle stolen from an Ontario street more than six months earlier. With Sept. 10 picked as the date for when the Conservative Party of Canada will have a new leader, time is ticking for prospective candidates and their teams to get into place. Trudeau announced Tuesday morning that the confidence-and-supply agreement has been brokered, and is effective immediately. "Aspirin might still make sense in some situations, where we're not doing as good a job controlling cholesterol, blood pressure, for whatever reason," Lloyd-Jones said. "When you look at all the studies that have been done recently, it seems that the modest benefit of aspirin and otherwise low-risk individuals is generally negated by the increase in long-term GI problems, bleeding with aspirin," Blumenthal said. These are not the only recommendations about daily aspirin use. "Modeling data suggest that it may be reasonable to consider stopping aspirin use around age 75 years." The last time the task force updated these recommendations, in 2016, it suggested that daily aspirin could be of benefit in colorectal cancer prevention. Low-dose aspirin was also associated with increases in the risk of bleeding. This means your chance of having a heart attack or stroke in the next 10 years is higher than normal, based on a calculation that includes factors like age, sex, race, cholesterol levels, blood pressure, medication use, diabetic status and smoking status. Your risk of bleeding will exceed the benefits," said Dr. Steven Nissen, chair of cardiovascular medicine at Cleveland Clinic, who was not involved in the new guidelines.
New recommendations on the use of low-dose aspirin to prevent a first heart attack or stroke say the blood thinner's risks may outweigh its benefits, ...
Wong said that quitting smoking, treating hypertension and monitoring blood pressure are also important tools to help prevent a heart attack or stroke. People ages 40 to 59 who are concerned about cardiovascular disease, should only use low-dose aspirin in consultation with a health care professional who can help weigh the individual benefits and risks. Aspirin's blood-thinning properties are a risk for those with other health conditions that may predispose them to bleeding. But before initiating the medication, people should talk to a doctor first. Current evidence highlighting the risks of internal bleeding associated with aspirin use prompted the U.S. Preventive Services Task Force to revise their 2016 guidelines. Untreated blood clots can lead to heart attack or stroke.
New recommendations on the use of low-dose aspirin to prevent a first heart attack or stroke say the blood thinner's risks may outweigh its benefits, ...
Wong said that quitting smoking, treating hypertension and monitoring blood pressure are also important tools to help prevent a heart attack or stroke. But before initiating the medication, people should talk to a doctor first. Aspirin’s blood-thinning properties are a risk for those with other health conditions that may predispose them to bleeding. People ages 40 to 59 who are concerned about cardiovascular disease, should only use low-dose aspirin in consultation with a health care professional who can help weigh the individual benefits and risks. Current evidence highlighting the risks of internal bleeding associated with aspirin use prompted the U.S. Preventive Services Task Force to revise their 2016 guidelines. Article content
In 2016, the U.S. Preventive Services Task Force (USPSTF) recommended that adults aged 50 to 59 years who were at risk for cardiovascular disease (CVD) ...
The final recommendations grant a C letter grade to the recommendation that those aged 40 to 59 with a 10% risk of developing CVD use preventive daily aspirin, and a D letter grade to adults aged 60 or older. “The USPSTF concludes with moderate certainty that aspirin use for the primary prevention of CVD events in adults aged 40 to 59 years who have a 10% or greater 10-year CVD risk has a small net benefit,” a USPSTF statement reads. In 2016, the U.S. Preventive Services Task Force (USPSTF) recommended that adults aged 50 to 59 years who were at risk for cardiovascular disease (CVD) should take a daily low-dose (75 to 100 milligrams) aspirin for heart attacks.
New USPTF recommendations align with 2019 American Heart Association guideline: low-dose aspirin not advised for people with no history of CVD or stroke.
The scientific evidence continues to confirm healthy lifestyle habits and effectively managing blood pressure and cholesterol are the top ways to prevent a first heart attack or stroke, not low-dose aspirin. Due to the blood-thinning effects of aspirin, research continues to indicate that for most adults the risk of bleeding may be greater than the number of heart attacks or strokes actually prevented. Some recent evidence also indicates some people with higher coronary calcium scores, >100 units, indicating higher plaque burden and risk, may also benefit from aspirin therapy if they have no history of prior bleeding.” “We continue to urge clinicians to be extremely selective when prescribing aspirin for adults without known cardiovascular disease. In consultation with their physician, select middle-aged adults may benefit from low-dose aspirin therapy if they are at high risk for heart attack or stroke due to risk factors such as smoking, hypertension, Type 2 diabetes, high cholesterol or significant family history. For people who have no history of cardiovascular disease or stroke, low-dose aspirin is not recommended for prevention of heart attack or stroke, particularly for adults with higher risk for bleeding.
New Recommendations Focus on Primary Prevention of a Cardiovascular Event · Evidence Shows the Modest Benefits of Aspirin in Preventing Heart Disease Often Don't ...
If your current risk level doesn’t indicate that aspirin is appropriate, there are still many ways to optimize your cardiovascular risk profile and reduce your chances of a first heart attack or stroke, says Wilkins: “In the past three years, there have been a couple of large randomized trials once again studying aspirin for preventative purposes. The last thing we want is for people who people who have had a procedure, such as having a stent put in, to stop their daily aspirin. “These recommendations only apply to the primary prevention group — they don’t apply in any way to people who already have established cardiovascular disease. For people age 60 or older, the panel recommends against starting low-dose aspirin for the primary prevention of CVD. “It’s very important to distinguish between primary and secondary prevention,” says Dr. Wilkins. Primary prevention recommendations are intended to prevent the first occurrence of a heart attack, stroke or a cardiovascular disease event, he says. Adults 60 and older who are at risk of heart disease should not start taking a daily low-dose aspirin to prevent heart attack or stroke, according to the United States Preventive Services Task Force (USPSTF), a panel of 18 independent experts appointed by the U.S. Department of Health and Human Services. The panel concluded with “moderate certainty” that initiating aspirin for the primary prevention of cardiovascular disease (CVD) events in this age group has no net benefit.